InvestorsHub Logo
Followers 32
Posts 3665
Boards Moderated 0
Alias Born 07/02/2004

Re: midastouch017 post# 130

Friday, 10/31/2014 7:50:14 AM

Friday, October 31, 2014 7:50:14 AM

Post# of 2048
This one is sooooooo far under the radar. With the current PPS and low share structure, a buy out ahead of q1 2015 phase 2/3 psoriasis results seems very possible imo.

One big drawback is the share price, which is well below the last offering at $5.15. Hopefully CANF's presentation at conference will convince a big boy to lay out 100 million for the patents....... or at least a good chunk of that for the rights to a % if/when cf101 is commercialized.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANF News